Cargando…
Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study
Immune thrombocytopenia (ITP) is an autoimmune disease which arises due to self-destruction of circulating platelets. Failure to respond or maintain a response to first-line treatment can lead to refractory/relapsed (R/R) ITP. The mechanism remains complicated and lacks a standard clinical treatment...
Autores principales: | Feng, Yimei, Xiao, Yunshuo, Yan, Hongju, Wang, Ping, Zhu, Wen, Cassady, Kaniel, Zou, Zhongmin, Wang, Kaifa, Chen, Ting, Quan, Yao, Wang, Zheng, Yang, Shijie, Wang, Rui, Li, Xiaoping, Gao, Lei, Zhang, Cheng, Liu, Yao, Kong, Peiyan, Gao, Li, Zhang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136762/ https://www.ncbi.nlm.nih.gov/pubmed/32296709 http://dx.doi.org/10.3389/fmed.2020.00110 |
Ejemplares similares
-
Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination
por: Feng, Yimei, et al.
Publicado: (2022) -
The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
por: Chen, Xiaoli, et al.
Publicado: (2021) -
Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
por: Feng, Yimei, et al.
Publicado: (2023) -
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
por: Feng, Yimei, et al.
Publicado: (2019) -
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
por: Feng, Yimei, et al.
Publicado: (2021)